FFA
AMED

Founders Financial Alliance’s Amedisys AMED Stock Holding History

Founders Financial Alliance’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-32
Closed -$7K – 456
2020
Q3 		$7K Buy
+32
New +$7.28K ﹤0.01% 866

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Founders Financial Alliance's AMED Position: Q4 2020 in Review

Founders Financial Alliance sold out of Amedisys (AMED) in Q4 2020, closing a stake of 32 shares — an estimated $7K sold.

Founders Financial Alliance first reported a position in AMED in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Founders Financial Alliance reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 32 Amedisys shares in Q4 2020, an estimated $7K.
  • Founders Financial Alliance first reported a position in Amedisys in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's Amedisys position peaked at $7K in Q3 2020.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.